On July 2, Nutraceuticals World featured remarks Todd Harrison made at the March Natural Products Expo West conference on, among other things, the role of the FDA in the CBD supplement sector.
Discussing the Federal Drug Enforcement Administration (DEA), Mr. Harrison said the agency still considers marijuana to be a Schedule 1 narcotic, despite any and all other state-level laws that rule otherwise. And by "marijuana," the DEA means all parts of the Cannabis sativa plant—the seeds, the leaves, the stalks, the resin, everything. Harrison also said there’s currently no legitimate way to claim CBD is a dietary supplement. The FDA has made it very clear that it does not consider CBD to be a dietary supplement.